173 related articles for article (PubMed ID: 10750252)
1. A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure. Irbesartan Heart Failure Group.
Tonkon M; Awan N; Niazi I; Hanley P; Baruch L; Wolf RA; Block AJ
Int J Clin Pract; 2000; 54(1):11-4, 16-8. PubMed ID: 10750252
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
Blanchet M; Sheppard R; Racine N; Ducharme A; Curnier D; Tardif JC; Sirois P; Lamoureux MC; De Champlain J; White M
Am Heart J; 2005 May; 149(5):938.e1-7. PubMed ID: 15894946
[TBL] [Abstract][Full Text] [Related]
3. Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure.
Havranek EP; Thomas I; Smith WB; Ponce GA; Bilsker M; Munger MA; Wolf RA
J Am Coll Cardiol; 1999 Apr; 33(5):1174-81. PubMed ID: 10193713
[TBL] [Abstract][Full Text] [Related]
4. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. A randomised, double-blind comparison of the angiotensin II receptor antagonist, irbesartan, with the full dose range of enalapril for the treatment of mild-to-moderate hypertension.
Mimran A; Ruilope L; Kerwin L; Nys M; Owens D; Kassler-Taub K; Osbakken M
J Hum Hypertens; 1998 Mar; 12(3):203-8. PubMed ID: 9579771
[TBL] [Abstract][Full Text] [Related]
7. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial.
McMurray JJ; Ostergren J; Swedberg K; Granger CB; Held P; Michelson EL; Olofsson B; Yusuf S; Pfeffer MA;
Lancet; 2003 Sep; 362(9386):767-71. PubMed ID: 13678869
[TBL] [Abstract][Full Text] [Related]
8. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ
J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind comparison of irbesartan and enalapril for treatment of mild to moderate hypertension.
Chiou KR; Chen CH; Ding PY; Chen YT; Ting CT; Huang JL; Chiang AH; Liu CP; Tseng CJ; Chao CT; Chang MS
Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):368-76. PubMed ID: 10862446
[TBL] [Abstract][Full Text] [Related]
10. The Hong Kong diastolic heart failure study: a randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction.
Yip GW; Wang M; Wang T; Chan S; Fung JW; Yeung L; Yip T; Lau ST; Lau CP; Tang MO; Yu CM; Sanderson JE
Heart; 2008 May; 94(5):573-80. PubMed ID: 18208835
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
Lang RM; Elkayam U; Yellen LG; Krauss D; McKelvie RS; Vaughan DE; Ney DE; Makris L; Chang PI
J Am Coll Cardiol; 1997 Oct; 30(4):983-91. PubMed ID: 9316528
[TBL] [Abstract][Full Text] [Related]
12. Effects and tolerability of irbesartan versus enalapril in patients with severe hypertension. Irbesartan Multicenter Investigators.
Larochelle P; Flack JM; Marbury TC; Sareli P; Krieger EM; Reeves RA
Am J Cardiol; 1997 Dec; 80(12):1613-5. PubMed ID: 9416950
[TBL] [Abstract][Full Text] [Related]
13. Cardiac autonomic tone during trandolapril-irbesartan low-dose combined therapy in hypertension: a pilot project.
Franchi F; Lazzeri C; Foschi M; Tosti-Guerra C; Barletta G
J Hum Hypertens; 2002 Aug; 16(8):597-604. PubMed ID: 12149667
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats.
Richer C; Fornes P; Cazaubon C; Domergue V; Nisato D; Giudicelli JF
Cardiovasc Res; 1999 Jan; 41(1):100-8. PubMed ID: 10325957
[TBL] [Abstract][Full Text] [Related]
15. Irbesartan in patients with heart failure and preserved ejection fraction.
Massie BM; Carson PE; McMurray JJ; Komajda M; McKelvie R; Zile MR; Anderson S; Donovan M; Iverson E; Staiger C; Ptaszynska A;
N Engl J Med; 2008 Dec; 359(23):2456-67. PubMed ID: 19001508
[TBL] [Abstract][Full Text] [Related]
16. Comparison of angiotensin-converting enzyme inhibitor alone and in combination with irbesartan for the treatment of heart failure.
Kum LC; Yip GW; Lee PW; Lam YY; Wu EB; Chan AK; Fung JW; Chan JY; Zhang Q; Kong SL; Yu CM
Int J Cardiol; 2008 Mar; 125(1):16-21. PubMed ID: 17433840
[TBL] [Abstract][Full Text] [Related]
17. Exploring new treatment strategies in heart failure.
Swedberg K
Blood Press Suppl; 2000; 1():44-8. PubMed ID: 11059637
[TBL] [Abstract][Full Text] [Related]
18. AT1-receptor antagonists for the treatment of chronic heart failure.
Baan J
Cardiovasc Res; 1999 Jan; 41(1):14-5. PubMed ID: 10325947
[No Abstract] [Full Text] [Related]
19. Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy.
Jacobsen P; Andersen S; Rossing K; Hansen BV; Parving HH
Nephrol Dial Transplant; 2002 Jun; 17(6):1019-24. PubMed ID: 12032191
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
